Sun, Dec 28, 2014
A A A
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Alternative Market Briefing

Alceda reports that demand for alternative UCITS continues

Thursday, October 31, 2013

Beverly Chandler, Opalesque London:

Alceda has published its quarterly review of alternative UCITS finding that with equity markets continuing their rally into the third quarter, the demand for alternative UCITS strategies has continued. The firm writes: "In particular we have seen a significant increase in the demand for equity strategies as investors increasingly appear to be seeking higher returns and diversification through alpha."

The new and revised universe of UCITS funds overseen by Alceda now includes 454 funds with assets under management of €154.5bn, a growth of 2.6% on the previous quarter.

The firm writes that after a difficult second quarter alternative UCITS strategies rebounded in Q3 with the AH Global UCITS Index advancing 1.09%. "The constructive equity market backdrop has proved fertile for Equity Long Short managers with the AH Equity Long Short Index the top performing alternative UCITS strategy this year up 7.68%. 2012 saw a similar pattern with Equity Long Short also leading alternative strategies with a return of 6.19%. Given this strong performance it is unsurprising that funds in this space have been generating strong investor interest, with strong net asset flows into equity strategies this year."

Equity Long Short UCITS funds have performed only marginally behind their offshore equivalent funds however they have achieved this with a lower level volatility. Alceda finds that on a risk adju......................

To view our full article Click here

Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing


  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Hong Kong-Shanghai stock link fails to live up to expectation so far[more]

    Komfie Manalo, Opalesque Asia: In a report, Reuters said that demand has been subdued with the bulk of activities coming from short-term speculative investors. Las

  2. Investing - Hedge funds get boost from healthcare in 2014, Paulson & Co takes stake in Salix on heels of inventory issues[more]

    Hedge funds get boost from healthcare in 2014 From Valuewalk.com: The healthcare sector started the year on a turbulent note, as stocks of many major biotechnology companies were battered. However, most of the players in this sector have bounced back. The BarclayHedge Healthcare & Biotec

  3. North America - Why Steve Cohen, Connecticut hedge fund billionaire, gives so much in New York[more]

    From Insidephilantrophy.com: Billionaire Steve Cohen was born in Great Neck, New York before attending Wharton, working on Wall Street and then founding SAC Capital Advisors in Connecticut. Though his company (Point72) and foundation are based in Connecticut, Cohen and Alexandra are deeply connected

  4. Investing - Soros buys a highly speculative biotech in the third quarter[more]

    From Fool.com: …The Soros Fund bought 25,000 shares of the struggling small-cap biopharma Aegerion Pharmaceuticals in the third quarter. For those of you who haven't heard of this name, suffice to say that this was a surprising buy in light of the company's recent problems and poor outlook going for

  5. CFTC Revokes Registrations of Illinois Resident Aleks A. Kins and Chicago-based AlphaMetrix, LLC[more]

    Matthias Knab, Opalesque: The U.S. Commodity Futures Trading Commission (CFTC) today announced that it has revoked the registration of Aleks A. Kins of Chicago, Illinois, as an Associated Person and the registrations of AlphaMetrix, LLC (AlphaMetrix), a Delaware limited liability company with its